97 related articles for article (PubMed ID: 2667428)
1. [Chediak-Higashi disease: a new case treated by bone marrow allograft].
Demory JL; Senlecq-Tack S; Decoster A; Duhamel M; Spyckerelle C; Vittu G; Cousin J; Fischer A; Griscelli C
Ann Pediatr (Paris); 1989 Jun; 36(6):387-9. PubMed ID: 2667428
[TBL] [Abstract][Full Text] [Related]
2. Split chimerism after allogeneic bone marrow transplantation in Chediak-Higashi syndrome.
Yamazaki S; Takahashi H; Fujii H; Miyamae T; Mori M; Fujioka K; Funabiki T; Yokota S; Arai N; Ikuta K
Bone Marrow Transplant; 2003 Jan; 31(2):137-40. PubMed ID: 12621497
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
4. [The accelerated phase of Chediak-Higashi syndrome].
Bejaoui M; Veber F; Girault D; Gaud C; Blanche S; Griscelli C; Fischer A
Arch Fr Pediatr; 1989 Dec; 46(10):733-6. PubMed ID: 2697195
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome.
Möttönen M; Lanning M; Saarinen UM
Pediatr Hematol Oncol; 1995; 12(1):55-9. PubMed ID: 7703042
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic cell transplantation for Chediak-Higashi syndrome.
Eapen M; DeLaat CA; Baker KS; Cairo MS; Cowan MJ; Kurtzberg J; Steward CG; Veys PA; Filipovich AH
Bone Marrow Transplant; 2007 Apr; 39(7):411-5. PubMed ID: 17293882
[TBL] [Abstract][Full Text] [Related]
7. Chédiak-Higashi syndrome: hematopoietic chimerism corrects genetic defect.
Trigg ME; Schugar R
Bone Marrow Transplant; 2001 Jun; 27(11):1211-3. PubMed ID: 11551033
[TBL] [Abstract][Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation in a patient with Chédiak-Higashi Syndrome.
Griscelli C; Virelizier JL
Birth Defects Orig Artic Ser; 1983; 19(3):333-4. PubMed ID: 6360244
[No Abstract] [Full Text] [Related]
10. Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
Haddad E; Le Deist F; Blanche S; Benkerrou M; Rohrlich P; Vilmer E; Griscelli C; Fischer A
Blood; 1995 Jun; 85(11):3328-33. PubMed ID: 7756666
[TBL] [Abstract][Full Text] [Related]
11. Restoration of neutrophil and platelet function in feline Chediak-Higashi syndrome by bone marrow transplantation.
Colgan SP; Hull-Thrall MA; Gasper PW; Gould DH; Rose BJ; Fulton R; Blanquaert AM; Bruyninckx WJ
Bone Marrow Transplant; 1991 May; 7(5):365-74. PubMed ID: 2070146
[TBL] [Abstract][Full Text] [Related]
12. Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: alloengraftment with potential preservation of fertility in women.
Singhal S; Powles R; Treleaven J; Horton C; Swansbury GJ; Mehta J
Bone Marrow Transplant; 1996 Dec; 18(6):1049-55. PubMed ID: 8971372
[TBL] [Abstract][Full Text] [Related]
13. Chediak-Higashi syndrome presenting in accelerated phase.
Imran T; Zafar L; Rehan M; Nasir A; Tariq PA; Batool I
J Coll Physicians Surg Pak; 2012 Aug; 22(8):539-41. PubMed ID: 22868026
[TBL] [Abstract][Full Text] [Related]
14. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
Vossen J
Verh K Acad Geneeskd Belg; 1998; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
17. [Role of splenectomy in Chediak-Higashi syndrome in its accelerated phase].
Ammaturo C; Giardiello C; Pascotto R; Correra A; Tontoli N; Pelliccia A; De Masi RV; Micheli P
Pediatr Med Chir; 1985; 7(4):593-7. PubMed ID: 3837224
[TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
19. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
Mitsuyasu RT; Li SN; Champlin RE; Gale RP
Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
[TBL] [Abstract][Full Text] [Related]
20. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
